Panbela Therapeutics logo
  • About Us
    • Company Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Our Science
    • Overview of SBP-101
    • Science
    • Pipeline
    • Clinical Trials
    • Expanded Access Policy
  • Newsroom
    • Press Releases
    • Events & Presentations
  • Investor Relations
    • Corporate Governance
    • Financial Information
    • Annual Reports & Proxy Statements
    • Investor Contact Info
  • Contact

Annual Reports & Proxy Statements

  • Overview
  • Corporate Governance
  • Financial Information
  • Annual Reports & Proxy Statements
  • Investor Contact Information

Sun BioPharma 2020 Annual Report including 2021 Proxy Statement »
Sun BioPharma 2019 Annual Report including 2020 Proxy Statement »
Sun BioPharma 2018 Annual Report including 2019 Proxy Statement »
Sun BioPharma 2017 Annual Report including 2018 Proxy Statement »
Sun BioPharma Notice of Consent Solicitation »
Sun BioPharma 2016 Annual Report including 2017 Proxy Statement »
Sun BioPharma 2015 Annual Report including 2016 Proxy Statement »

Quick Links

  • Home
  • About Us
  • Our Science
  • Newsroom
  • Investor Relations
  • Contact

Contact

ir@panbela.com
 
Sign up to receive press releases via email:

News & Events

Panbela to Present at Upcoming Investor Conferences

Panbela Provides Business Update and Reports Q2 2021 Financial Results

Panbela Announces Issuance of key U.S. Patent; Patent is for Claims of a Novel Process for the Production of SBP-101

Copyright ©2021 Panbela Therapeutics, Inc. All Rights Reserved.